M. Febbraio et al., Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice, J CLIN INV, 105(8), 2000, pp. 1049-1056
Macrophage scavenger receptors have been implicated as key players in the p
athogenesis of atherosclerosis. To assess the role of the class B scavenger
receptor CD36 in atherogenesis, we crossed a CD35-null strain with the ath
erogenic apo E-null strain and quantified lesion development. There was a 7
6.5% decrease in aortic tree lesion area (Western diet) and a 45% decrease
in aortic sinus lesion area (normal chow) in the CD36-apo E double-null mic
e when compared with controls, despite alterations in lipoprotein profiles
that often correlate with increased atherogenicity. Macrophages derived fro
m CD36-apo E double-null mice bound and internalized more than 60% less cop
per-oxidized LDL and LDL modified by monocyte-generated reactive nitrogen s
pecies. A similar inhibition of in vitro lipid accumulation and foam cell f
ormation after exposure to these Ligands was seen. These results support a
major role for CD36 in atherosclerotic lesion development in vivo and sugge
st that blockade of CD36 can be protective even in more extreme proatheroge
nic circumstances.